JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

Business by 2FIRSTS
Jun.06.2024
JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
JSTE Technology Mr. Liu De Wen responds to JFT's creditor letter, claiming it contains falsehoods. The full statement follows.

On June 6th at noon, Mr. Liu Dewen, the head of JSTE Electronic Technology (Dongguan) Co., Ltd., publicly responded to the "Letter to Creditors" released by JFT, stating that the letter contained falsehoods.

 

The complete response is as follows:

 

JFT Company confirmed in a December 2021 email that they had acquired a 50% stake in our JSTE factory, but they suddenly changed their minds in September 2022 and decided to sell their stake instead of acquiring it. They officially exited JSTE in January 2023 and received a significant amount of money from the stock transfer.

During the equity exit process, JFT company confirmed the value of over 60 million worth of JUSTFOG brand e-cigarettes under the original processing agreement, but they have been delaying payment and not taking delivery. After several months of dragging their feet, they suddenly notified of the termination of the processing partnership, leaving Jest in a difficult situation.

 

However, the European agents of JFT company continue to authorize domestic licensed trading companies to request small batches of JUSTFOG branded e-cigarettes for sale. Unfortunately, this led to a criminal charge of trademark infringement by JFT, claiming that the e-cigarettes produced under the original agreement were unauthorized. The malicious intent behind this action is surprising, and this absurdity cannot be justified. Jast company reserves the right to hold the criminal plaintiff accountable for their legal responsibility.

 

Subsequently, Jast Company employed legal methods such as litigation and arbitration to seek compensation, and successfully obtained an injunction to preserve JFT Company’s registered trademarks (such as JUSTFOG) in China, as well as its fully-owned subsidiary’s bank accounts and patents related to the e-cigarette business in China. The breach of contract case is scheduled to be heard in the near future.

 

At the same time, Gest also filed a patent confirmation lawsuit to the court. During the cooperation between both parties, JFT appointed a research and development manager who established a labor relationship with Gest, and transferred numerous patents to its wholly-owned subsidiary, severely infringing on Gest's rights.

 

As a leading media and think tank in the field of atomization technology, 2FIRSTS closely monitors the latest developments on this issue and maintains contact with various parties.


 

Click on the image to read: "Vape Debt Risk: How can the operational difficulties of a single company affect the entire industry chain?"

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

 

Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations".

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations"

 

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
British American Tobacco’s New Category revenue rose 18% at constant rates in the first half of 2026. Nicotine-pouch brand Velo expanded rapidly, while Vuse recovered as U.S. enforcement against illicit e-vapor products strengthened. Heated-tobacco platform glo remained under pressure, and cigarettes continued to provide most of the group’s profit and cash. Compared with PMI and JT, BAT has more routes to growth—but also greater regulatory, investment and execution risks across its broader portfolio.
BAT
Jul.30
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives